BriaCell Therapeutics Corp. Quarterly Depreciation, Depletion and Amortization in USD from Q3 2021 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
Summary
BriaCell Therapeutics Corp. quarterly/annual Depreciation, Depletion and Amortization history and growth rate from Q3 2021 to Q3 2022.
  • BriaCell Therapeutics Corp. Depreciation, Depletion and Amortization for the quarter ending October 31, 2022 was $3.82K, a 0.03% increase year-over-year.
  • BriaCell Therapeutics Corp. annual Depreciation, Depletion and Amortization for 2022 was $15.3K, a 0.11% increase from 2021.
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 $3.82K +$1.00 +0.03% Aug 1, 2022 Oct 31, 2022 10-Q 2022-12-14
Q3 2021 $3.82K Aug 1, 2021 Oct 31, 2021 10-Q 2022-12-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.